EcoR1 Capital, LLC Q1 2017 Filing

Filed May 15, 2017

Portfolio Value

$395.6B

Holdings

33

Report Date

Q1 2017

Filing Type

13F-HR

All Holdings (33 positions)

#StockSharesValue% PortfolioType
1
ASMBASSEMBLY BIOSCIENCES INC
2,943,164$75.0B18.97%
2
IRWDIRONWOOD PHARMACEUTICALS INC
2,905,515$49.6B12.53%
3
GLPGGALAPAGOS NV
551,041$47.5B12.01%
4
GILDGILEAD SCIENCES INC
500,000$34.0B8.59%Call
5
ASNDASCENDIS PHARMA A S
1,025,700$28.7B7.26%
6
KURAKURA ONCOLOGY INC COM
2,611,906$23.0B5.81%
7
INVA 2.125 01/15/23THERAVANCE BIOPHARMA INC
17,000,000$21.4B5.42%
8
ACRSACLARIS THERAPEUTICS INC
673,100$20.1B5.07%
9
CTMXCYTOMX THERAPEUTICS INC
794,969$13.7B3.47%
10
CASCADIAN THERAPEUTICS INC
3,000,000$12.4B3.14%
11
FATEFATE THERAPEUTICS INC
2,537,026$11.5B2.92%
12
ATRAGBXATARA BIOTHERAPEUTICS INC
434,812$8.9B2.26%
13
ATYR PHARMA INC
2,292,659$8.0B2.03%
14
OVASCIENCE INC
3,512,332$6.6B1.66%
15
JNCEEURJOUNCE THERAPEUTICS INC
258,457$5.7B1.44%
16
XNCRXENCOR INC
234,813$5.6B1.42%
17
KINDRED BIOSCIENCES INC
544,880$3.8B0.97%
18
NABRIVA THERAPEUTICS AG
264,773$3.2B0.80%
19
REGULUS THERAPEUTICS INC
1,510,000$2.5B0.63%
20
ADVMCHFADVERUM BIOTECHNOLOGIES INC
874,447$2.4B0.60%
21
VERSARTIS INC
100,000$2.1B0.54%
22
VIVEVE MED INC
250,000$1.6B0.40%
23
AGIOAGIOS PHARMACEUTICALS INC
23,300$1.4B0.34%
24
DICERNA PHARMACEUTICALS INC
382,000$1.3B0.33%
25
FGENEURFIBROGEN INC
42,009$1.0B0.26%
26
SYROS PHARMACEUTICALS INC
63,596$1.0B0.26%
27
BMYBRISTOL MYERS SQUIBB CO
17,060$928.0M0.23%
28
CHEMOCENTRYX INC
118,000$859.0M0.22%
29
SNDXSYNDAX PHARMACEUTICALS INC COM
35,301$484.0M0.12%
30
CASCADIAN THERAPEUTICS INC
103,800$430.0M0.11%Call
31
OREXIGEN THERAPEUTICS INC
117,726$405.0M0.10%
32
WVEWAVE LIFE SCIENCES LTD
10,000$275.0M0.07%
33
FORWARD PHARMA A/S
5,025$108.0M0.03%